|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
11
|
|
pubmed:dateCreated |
2009-10-28
|
|
pubmed:abstractText |
Platinum compounds, taxanes and anthracyclines provide the major effective drug classes in the treatment of advanced and recurrent endometrial cancer and carcinosarcoma.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
1569-8041
|
|
pubmed:author |
pubmed-author:A'HernRR,
pubmed-author:AngJ EJE,
pubmed-author:BlakePP,
pubmed-author:CoomberJJ,
pubmed-author:EverardMM,
pubmed-author:GabraHH,
pubmed-author:GoreM EME,
pubmed-author:HallGG,
pubmed-author:JenkinsAA,
pubmed-author:JonesR LRL,
pubmed-author:KayeS BSB,
pubmed-author:KeyzorCC,
pubmed-author:ShahR NRN,
pubmed-author:ThomasKK
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
20
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1787-93
|
|
pubmed:dateRevised |
2010-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:19542250-Adenocarcinoma,
pubmed-meshheading:19542250-Adult,
pubmed-meshheading:19542250-Aged,
pubmed-meshheading:19542250-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:19542250-Carboplatin,
pubmed-meshheading:19542250-Carcinosarcoma,
pubmed-meshheading:19542250-Combined Modality Therapy,
pubmed-meshheading:19542250-Disease-Free Survival,
pubmed-meshheading:19542250-Doxorubicin,
pubmed-meshheading:19542250-Endometrial Neoplasms,
pubmed-meshheading:19542250-Feasibility Studies,
pubmed-meshheading:19542250-Female,
pubmed-meshheading:19542250-Humans,
pubmed-meshheading:19542250-Kaplan-Meier Estimate,
pubmed-meshheading:19542250-Middle Aged,
pubmed-meshheading:19542250-Neoplasm Recurrence, Local,
pubmed-meshheading:19542250-Neoplasm Staging,
pubmed-meshheading:19542250-Paclitaxel
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
A feasibility study of sequential doublet chemotherapy comprising carboplatin-doxorubicin and carboplatin-paclitaxel for advanced endometrial adenocarcinoma and carcinosarcoma.
|
|
pubmed:affiliation |
Royal Marsden Hospital, London and Sutton, Surrey, UK.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, Non-U.S. Gov't
|
